Skip to main content
Alteogen Inc. logo

Alteogen Inc. — Investor Relations & Filings

Ticker · 196170 ISIN · KR7196170005 KO Professional, scientific and technical activities
Open in API
Filings indexed 293 across all filing types
Latest filing 2022-12-05 Declaration of Voting R…
Country KR South Korea
Listing KO 196170

About Alteogen Inc.

http://www.alteogen.com/

Alteogen Inc. is a biopharmaceutical company focused on the development and commercialization of next-generation biologics. The company's core activities are centered on its proprietary platform technologies. These include Hybrozyme™, a novel recombinant human hyaluronidase (ALT-B4) technology that enables the conversion of intravenous (IV) therapies to subcutaneous (SC) formulations, enhancing patient convenience. Additionally, Alteogen develops long-acting biobetters utilizing its NexP™ fusion technology, proprietary antibody-drug conjugates (ADCs), and antibody biosimilars. The company's pipeline is aimed at creating therapies with enhanced efficacy and delivery methods for serious diseases.

Recent filings

Filing Released Lang Actions
임시주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled '임시주주총회결과' (Extraordinary General Meeting Results) and explicitly lists the agenda items and the approval status of the resolutions passed during the meeting held on 2022-12-05. This fits the definition of a Declaration of Voting Results & Voting Rights Announcement (DVA).
2022-12-05 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a formal 'Notice of Extraordinary General Meeting of Shareholders' (주주총회소집공고) for Alteogen Inc. It includes the meeting agenda, voting procedures, electronic voting instructions, and required management disclosures (such as board activities and major shareholder transactions). This document is a standard proxy statement/notice sent to shareholders to inform them of an upcoming meeting and solicit their participation/votes. According to the provided definitions, this fits the 'Proxy Solicitation & Information Statement' (PSI) category.
2022-11-18 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled '의결권대리행사권유참고서류' (Reference Document for Solicitation of Proxy), which is a standard regulatory filing in South Korea used by companies to solicit proxies from shareholders for an upcoming general meeting. It details the purpose of the meeting, the agenda items (such as capital reduction and deficit compensation), and instructions for voting. This falls under the category of Proxy Solicitation & Information Statement.
2022-11-18 Korean
[기재정정]주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice regarding the convocation of an Extraordinary General Meeting (EGM) for the company Alteogen. It details the agenda items, meeting date, location, and specifically notes a correction (amendment) to the previously filed notice regarding the meeting agenda. This falls under the category of Proxy Solicitation & Information Statement (PSI) as it provides shareholders with the necessary information and agenda for an upcoming meeting.
2022-11-15 Korean
분기보고서 (2022.09)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for the 3rd quarter of 2022 for Alteogen Inc. It contains detailed financial information, business operations, capital structure, and management discussions, which are characteristic of an Interim/Quarterly Report (IR). It is not an announcement of a report, but the report itself. 9M 2022
2022-11-11 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). It details the shareholding changes of a director (Park Soon-jae) of Alteogen. This type of filing is a standard regulatory requirement for insider trading or changes in ownership by company directors/executives, which corresponds to the 'Director's Dealing' category.
2022-11-10 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.